RE: Loan Notes8 Aug 2019 10:10
morning bignose.interesting thoughts.im not sure id read anything particular into the wording of the loan note document itself as I'm pretty sure thats just standard wording for this type of arrangement and not particular to regent(could always be wrong of course).that said as you rightly point out there have been some strange activities over the years and i do agree that its odd that no shares were issued under the option scheme.maybe there is some master plan or perhaps more likely the knowledge that in the right circumstances there is an interested party waiting in the wings if FDA approval seems on the cards.personally i do not see anyone actually acquiring fortacin without evidence of hard sales or formal FDA approval but anything is possible i suppose.what will be interesting is to see where the company's focus is if they do come up with a concrete cannabis tie in of some sort.will they then start to see fortacin as a secondary aspect making a possible sale of the rights more likely?my initial thought after the yoyo news was that was quite likely but after further thought and in light of your post yesterday i am more inclined to think that they will try and retain fortacin to get it to FDA approval which has always been,as we say,the holy grail.what will be interesting is how they get there and what income they can generate to keep going.looking forward(not sure thats quite the way to put it as its usually fingers over the eyes time) to next update.oh and currently up almost 6% on tiny volume!